Disc Medicine Stock Forecast
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:49 PM ET
IRON analyst consensus
Consensus (13 analysts)
strong_buy
Avg. price target
$103.17+63.58%
- Strong buy 1
- Buy 12
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 13 Wall Street analysts covering Disc Medicine (2026-10-07), 13 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $103.17, with a high estimate of $128.00 and a low estimate of $83.00. The average target implies upside of 63.6% from the current price of $63.07.
The spread between the highest and lowest targets is 54.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for IRON.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 8% |
| Buy | 12 | 92% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $83.00 | +31.60% |
| Average target | $103.17 | +63.58% |
| High target | $128.00 | +102.95% |